Filter Results:
(5,085)
Show Results For
- All HBS Web
(5,085)
- People (18)
- News (1,641)
- Research (2,747)
- Events (5)
- Multimedia (111)
- Faculty Publications (1,760)
Show Results For
- All HBS Web
(5,085)
- People (18)
- News (1,641)
- Research (2,747)
- Events (5)
- Multimedia (111)
- Faculty Publications (1,760)
- 29 May 2014
- Research & Ideas
Research Symposium 2014
to find ways to get our students to engage with this idea," he said. "Our students will be tomorrow's participants in thin political markets." (To learn more about thin political markets, see the story A Manager's Moral Obligation to... View Details
- 30 Jan 2018
- Blog Post
HBS Global Opportunity Fellowship: Making a Difference in Africa
internet speeds that are higher than some developed countries, developed one of the hottest real estate markets in the world, and cultivated one of Africa’s foremost innovation hubs. And yet, there is so... View Details
- 20 Mar 2020
- News
How grocery stores restock shelves in the age of coronavirus
- 16 Apr 2019
- First Look
New Research and Ideas, April 16, 2019
all become consumers of the health care industry. Indeed, health care affects everyone and encompasses a diverse set of services from childbirth,... View Details
Keywords: Dina Gerdeman
- 02 Dec 2021
- News
Our Eight Favorite Books in 2021 for Healthy Living
- February 1999 (Revised November 1999)
- Case
HealthPartners
By: Richard M.J. Bohmer and Nancy Dean Beaulieu
Presents the efforts by HealthPartners to create competition among health care providers in Minnesota on the basis of both quality and price. Also provides some insight into the strategies for changing physician behavior. View Details
Keywords: Health Care and Treatment; Service Delivery; Behavior; Competition; Health Industry; Minnesota
Bohmer, Richard M.J., and Nancy Dean Beaulieu. "HealthPartners." Harvard Business School Case 699-131, February 1999. (Revised November 1999.)
- June 2020
- Article
Waiting to Inhale: Reducing Stigma in the Medical Cannabis Industry
By: Kisha Lashley and Timothy G. Pollock
When a new industry category is predicated on a product or activity subject to ‘‘core’’ stigma—meaning its very nature is stigmatized—the actors trying to establish it may struggle to gain the resources they need to survive and grow. To explain the process of reducing... View Details
Keywords: Stigma; Cannabis Industry; Deviance; Public Opinion; Moral Sensibility; Health Care and Treatment
Lashley, Kisha, and Timothy G. Pollock. "Waiting to Inhale: Reducing Stigma in the Medical Cannabis Industry." Administrative Science Quarterly 65, no. 2 (June 2020): 434–482.
- August 2016 (Revised August 2016)
- Teaching Note
Intrapreneurship at DaVita Healthcare Partners
By: Joseph B. Fuller and Matthew Preble
DaVita Healthcare Partners Inc. (DaVita) is one of the U.S.'s leading dialysis providers, a process whereby persons with end-stage renal disease (ESRD) are connected to a machine that performs the functions of a healthy kidney. Kent Thiry, DaVita's CEO, has expanded... View Details
- 15 Sep 2007
- News
Managing Outcomes Helps a Children’s Hospital Climb in Renown
- October 22, 2015
- Article
The Mayo Clinic Model for Running a Value-Improvement Program
By: Robert S. Kaplan, Derek A. Haas, Richard A. Helmers, March Rucci and Meredith Brady
Applying time-driven activity-based costing (TDABC) in health care cannot be delegated to the finance function. The most successful implementations have had strong executive support, exceptional clinical leaders, and dedicated, multi-disciplinary project teams. The... View Details
Keywords: Service Delivery; Activity Based Costing and Management; Health Care and Treatment; Health Industry
Kaplan, Robert S., Derek A. Haas, Richard A. Helmers, March Rucci, and Meredith Brady. "The Mayo Clinic Model for Running a Value-Improvement Program." Harvard Business Review (website) (October 22, 2015). (A collaboration of the editors of Harvard Business Review and the New England Journal of Medicine.)
- 27 Aug 2013
- First Look
First Look: August 27
representative samples of Americans with private health insurance. The first examines how well Americans understand, and believe they understand, traditional health insurance coverage. The second examines... View Details
Keywords: Sean Silverthorne
- 15 May 2007
- Working Paper Summaries
I’ll Have the Ice Cream Soon and the Vegetables Later: Decreasing Impatience over Time in Online Grocery Orders
- 15 Mar 2020
- News
Commercial Real Estate in the Age of the COVID-19 Virus
- November 2017
- Article
A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies
By: S. Balsari, P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough and T. Khanna
Cardiovascular disease is the leading cause of mortality from noncommunicable diseases (NCD) in India. The government’s National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke seeks to increase capacity building, screening,... View Details
Balsari, S., P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough, and T. Khanna. "A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies." Journal of Human Hypertension 31, no. 11 (November 2017): 750–753.
- February 2006 (Revised April 2006)
- Case
Grove International Partners
By: Robert F. Higgins, Carin-Isabel Knoop and Suzanne Petrela
Grove International Partners, one of the world's largest international real estate private equity funds, is actively seeking new investment opportunities in the seniors housing industry. The firm has identified two potential opportunities--one located in Japan and one... View Details
Keywords: Decision Choices and Conditions; Private Equity; Investment; Opportunities; Health Industry; Health Industry; Japan; United Kingdom
Higgins, Robert F., Carin-Isabel Knoop, and Suzanne Petrela. "Grove International Partners." Harvard Business School Case 806-096, February 2006. (Revised April 2006.)
- Web
BiGS Research | Institute for Business in Global Society
for entrepreneurship at HBS. Health Care Initiative With global health care spending greater than $8.5 trillion, there is no shortage of... View Details
- Fast Answer
Pharmaceuticals: drug approval dates in the UK and Europe
Where can I find drug approval dates for the UK? The European Medicines Agency provides information on drug approvals in the UK and Europe: EMA Annual Reports and Work Programmes provides list of new medicines with View Details
- 28 Mar 2018
- News